Secondary cytoreduction for relapsed ovarian cancer - Authors' reply.

Chen, Yulian; Shi, Tingyan; Liu, Jihong; Zhu, Jianqing; Zang, Rongyu

Chen, Yulian; Shi, Tingyan; Liu, Jihong; Zhu, Jianqing; Zang, Rongyu.

Afiliação

Chen Y; Ovarian Cancer Program, Department of Gynaecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Shi T; Ovarian Cancer Program, Department of Gynaecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Liu J; Department of Gynaecologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, China.
Zhu J; Department of Gynaecologic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Zang R; Ovarian Cancer Program, Department of Gynaecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: zang.rongyu@zs-hospital.sh.cn.

Lancet Oncol ; 22(6): e233, 2021 06.

Article em En | MEDLINE | ID: mdl-34087142

Assuntos

Neoplasias Epiteliais e Glandulares; Neoplasias Ovarianas; Carcinoma Epitelial do Ovário/cirurgia; Procedimentos Cirúrgicos de Citorredução/efeitos adversos; Feminino; Humanos; Recidiva Local de Neoplasia/cirurgia; Neoplasias Ovarianas/cirurgia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Epiteliais e Glandulares Limite: Female / Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google